Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$12.2 million.

  • Wave Life Sciences' Net Cash Flow fell 10779.04% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$114.6 million, marking a year-over-year decrease of 16702.82%. This contributed to the annual value of $101.9 million for FY2024, which is 898.49% down from last year.
  • As of Q3 2025, Wave Life Sciences' Net Cash Flow stood at -$12.2 million, which was down 10779.04% from -$34.6 million recorded in Q2 2025.
  • Over the past 5 years, Wave Life Sciences' Net Cash Flow peaked at $156.9 million during Q3 2024, and registered a low of -$88.8 million during Q1 2022.
  • In the last 5 years, Wave Life Sciences' Net Cash Flow had a median value of -$19.3 million in 2024 and averaged $655000.0.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 141186.37% in 2022, then plummeted by 20533.64% in 2025.
  • Over the past 5 years, Wave Life Sciences' Net Cash Flow (Quarter) stood at $26.7 million in 2021, then plummeted by 131.95% to -$8.5 million in 2022, then surged by 806.46% to $60.4 million in 2023, then crashed by 114.5% to -$8.8 million in 2024, then plummeted by 39.63% to -$12.2 million in 2025.
  • Its last three reported values are -$12.2 million in Q3 2025, -$34.6 million for Q2 2025, and -$59.0 million during Q1 2025.